Mark Reno, DO - Medicare Anesthesiology in New Albany, OH

Mark Reno, DO is a medicare enrolled "Anesthesiology" physician in New Albany, Ohio. His current practice location is 7333 Smiths Mill Rd, New Albany, Ohio. You can reach out to his office (for appointments etc.) via phone at (614) 775-6340.

Mark Reno is licensed to practice in Ohio (license number 34-008024) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1497788566.

Contact Information

Mark Reno, DO
7333 Smiths Mill Rd,
New Albany, OH 43054-9291
(614) 775-6340
Not Available



Physician's Profile

Full NameMark Reno
GenderMale
SpecialityAnesthesiology
Location7333 Smiths Mill Rd, New Albany, Ohio
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1497788566
  • Provider Enumeration Date: 07/09/2006
  • Last Update Date: 11/09/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 1951362292
  • Enrollment ID: I20050214000444

Medical Identifiers

Medical identifiers for Mark Reno such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1497788566NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207L00000XAnesthesiology 34-008024 (Ohio)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Mark Reno allows following entities to bill medicare on his behalf.
Entity NameNew Albany Orthopedic Anesthesia Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1093762635
PECOS PAC ID: 7618872789
Enrollment ID: O20031203000000

News Archive

Scientists take the first step to targeted treatment for stomach cancer

Researchers have identified a protein that plays an important role in the development of stomach cancers and that could one day be a target for new treatments for the disease, according to research published (Wednesday) in the British Journal of Cancer.

New mouse models can help scientists study MCT8 deficiency

New mouse models can help scientists study MCT8 deficiency, an inherited genetic disorder affecting children, according to new data presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada.

Afinitor-Sandostatin LAR Depot combination extends median PFS in patients with advanced carcinoid tumors

A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.

Research suggests contributory role of 'Asian glow' mutation and alcohol to Alzheimer's

A new study from Stanford, published on December 12 in the journal Acta Neuropathologica Communications, suggests that an important enzyme that helps break down alcohol in the body is defective in patients with Alzheimer's disease (AD). Understanding its relationship with alcohol and with genes that predispose to AD could help avert the latter in humans at risk.

Read more Medical News

› Verified 5 days ago

Entity NameMarietta Memorial Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1215936927
PECOS PAC ID: 8224928965
Enrollment ID: O20040317000973

News Archive

Scientists take the first step to targeted treatment for stomach cancer

Researchers have identified a protein that plays an important role in the development of stomach cancers and that could one day be a target for new treatments for the disease, according to research published (Wednesday) in the British Journal of Cancer.

New mouse models can help scientists study MCT8 deficiency

New mouse models can help scientists study MCT8 deficiency, an inherited genetic disorder affecting children, according to new data presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada.

Afinitor-Sandostatin LAR Depot combination extends median PFS in patients with advanced carcinoid tumors

A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.

Research suggests contributory role of 'Asian glow' mutation and alcohol to Alzheimer's

A new study from Stanford, published on December 12 in the journal Acta Neuropathologica Communications, suggests that an important enzyme that helps break down alcohol in the body is defective in patients with Alzheimer's disease (AD). Understanding its relationship with alcohol and with genes that predispose to AD could help avert the latter in humans at risk.

Read more Medical News

› Verified 5 days ago

Entity NameOsu Observation Medicine, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1407095052
PECOS PAC ID: 3375692270
Enrollment ID: O20090526000354

News Archive

Scientists take the first step to targeted treatment for stomach cancer

Researchers have identified a protein that plays an important role in the development of stomach cancers and that could one day be a target for new treatments for the disease, according to research published (Wednesday) in the British Journal of Cancer.

New mouse models can help scientists study MCT8 deficiency

New mouse models can help scientists study MCT8 deficiency, an inherited genetic disorder affecting children, according to new data presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada.

Afinitor-Sandostatin LAR Depot combination extends median PFS in patients with advanced carcinoid tumors

A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.

Research suggests contributory role of 'Asian glow' mutation and alcohol to Alzheimer's

A new study from Stanford, published on December 12 in the journal Acta Neuropathologica Communications, suggests that an important enzyme that helps break down alcohol in the body is defective in patients with Alzheimer's disease (AD). Understanding its relationship with alcohol and with genes that predispose to AD could help avert the latter in humans at risk.

Read more Medical News

› Verified 5 days ago

Entity NameArlington Anesthesia Partners Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1578209342
PECOS PAC ID: 7618344698
Enrollment ID: O20221103002030

News Archive

Scientists take the first step to targeted treatment for stomach cancer

Researchers have identified a protein that plays an important role in the development of stomach cancers and that could one day be a target for new treatments for the disease, according to research published (Wednesday) in the British Journal of Cancer.

New mouse models can help scientists study MCT8 deficiency

New mouse models can help scientists study MCT8 deficiency, an inherited genetic disorder affecting children, according to new data presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada.

Afinitor-Sandostatin LAR Depot combination extends median PFS in patients with advanced carcinoid tumors

A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.

Research suggests contributory role of 'Asian glow' mutation and alcohol to Alzheimer's

A new study from Stanford, published on December 12 in the journal Acta Neuropathologica Communications, suggests that an important enzyme that helps break down alcohol in the body is defective in patients with Alzheimer's disease (AD). Understanding its relationship with alcohol and with genes that predispose to AD could help avert the latter in humans at risk.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mark Reno is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Mark Reno, DO
1163 Weybridge Rd,
Columbus, OH 43220-3152

Ph: () -
Mark Reno, DO
7333 Smiths Mill Rd,
New Albany, OH 43054-9291

Ph: (614) 775-6340

News Archive

Scientists take the first step to targeted treatment for stomach cancer

Researchers have identified a protein that plays an important role in the development of stomach cancers and that could one day be a target for new treatments for the disease, according to research published (Wednesday) in the British Journal of Cancer.

New mouse models can help scientists study MCT8 deficiency

New mouse models can help scientists study MCT8 deficiency, an inherited genetic disorder affecting children, according to new data presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada.

Afinitor-Sandostatin LAR Depot combination extends median PFS in patients with advanced carcinoid tumors

A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.

Research suggests contributory role of 'Asian glow' mutation and alcohol to Alzheimer's

A new study from Stanford, published on December 12 in the journal Acta Neuropathologica Communications, suggests that an important enzyme that helps break down alcohol in the body is defective in patients with Alzheimer's disease (AD). Understanding its relationship with alcohol and with genes that predispose to AD could help avert the latter in humans at risk.

Read more News

› Verified 5 days ago


Anesthesiology Doctors in New Albany, OH

Dr. Victor Terebuh, M.D.
Anesthesiology
Medicare: Medicare Enrolled
Practice Location: 7333 Smiths Mill Rd, New Albany, OH 43054
Phone: 614-775-6340    Fax: 614-775-5077
Ryan Patrick Mccafferty, D.O.
Anesthesiology
Medicare: Accepting Medicare Assignments
Practice Location: 5031 Forest Dr Ste C, New Albany, OH 43054
Phone: 614-939-5416    
James L Steen, CRNA
Anesthesiology
Medicare: Accepting Medicare Assignments
Practice Location: 6520 West Campus Oval, Central Ohio Surgical Institute, New Albany, OH 43054
Phone: 614-413-2233    Fax: 614-413-2234
Dr. Steven Scott Lechiara, M.D.
Anesthesiology
Medicare: Accepting Medicare Assignments
Practice Location: 7333 Smiths Mill Rd, New Albany, OH 43054
Phone: 614-775-6340    
Daniel Patrick Pap, MD
Anesthesiology
Medicare: Accepting Medicare Assignments
Practice Location: 5040 Forest Dr Ste 300, New Albany, OH 43054
Phone: 614-890-6555    Fax: 614-523-7557
Rebecca S Keylor, CRNA
Anesthesiology
Medicare: Not Enrolled in Medicare
Practice Location: 6520 West Campus Oval, Central Ohio Surgical Institute, New Albany, OH 43054
Phone: 614-413-2233    Fax: 614-413-2234
Dr. Junaid Mukhdomi, M.D.
Anesthesiology
Medicare: Medicare Enrolled
Practice Location: 5031 Forest Dr Ste C, New Albany, OH 43054
Phone: 614-647-2526    Fax: 877-409-2415

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.